Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Gem Aromatics
Quarter-by-quarter operating performance
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 92.67 | 112.22 | 96.84 | 202.22 | 87.63 | 89.53 | 78.90 | 110.41 |
| Expenses + | 78.46 | 96.87 | 83.81 | 156.35 | 72.77 | 86.48 | 71.88 | 94.70 |
| Operating Profit | 14.21 | 15.35 | 13.03 | 45.87 | 14.86 | 3.05 | 7.02 | 15.71 |
| OPM % | 15.33% | 13.68% | 13.46% | 22.68% | 16.96% | 3.41% | 8.90% | 14.23% |
| Other Income + | 0.89 | 0.73 | 0.50 | -0.43 | 1.27 | 0.98 | -1.66 | 0.30 |
| Interest | 1.10 | 1.33 | 2.22 | 3.44 | 3.52 | 3.50 | 2.58 | 2.97 |
| Depreciation | 1.69 | 1.84 | 1.89 | 1.92 | 1.82 | 3.05 | 8.71 | 9.01 |
| Profit before tax | 12.31 | 12.91 | 9.42 | 40.08 | 10.79 | -2.52 | -5.93 | 4.03 |
| Tax % | 30.30% | 24.63% | 20.81% | 31.11% | 25.95% | 2.38% | -15.85% | 74.94% |
| Net Profit + | 8.59 | 9.74 | 7.46 | 27.60 | 7.98 | -2.58 | -4.99 | 1.01 |
| EPS in Rs | 1.83 | 2.08 | 1.59 | 5.89 | 1.70 | -0.49 | -0.96 | 0.19 |
Financials of Gem Aromatics
Annual income statement trend
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales + | 306 | 314 | 425 | 452 | 504 | 366 |
| Expenses + | 275 | 265 | 359 | 374 | 416 | 326 |
| Operating Profit | 31 | 49 | 66 | 78 | 88 | 41 |
| OPM % | 10% | 16% | 16% | 17% | 18% | 11% |
| Other Income + | 4 | 3 | 0 | 2 | 2 | 1 |
| Interest | 2 | 3 | 6 | 6 | 8 | 13 |
| Depreciation | 3 | 4 | 5 | 6 | 7 | 23 |
| Profit before tax | 30 | 44 | 56 | 68 | 75 | 6 |
| Tax % | 23% | 30% | 20% | 26% | 29% | 78% |
| Net Profit + | 23 | 31 | 45 | 50 | 53 | 1 |
| EPS in Rs | 129.92 | 174.74 | 250.27 | 10.69 | 11.39 | 0.27 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Gem Aromatics
Capital structure and asset base
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 9 | 9 | 10 |
| Reserves | 108 | 136 | 178 | 221 | 275 | 439 |
| Borrowings + | 55 | 78 | 90 | 112 | 225 | 152 |
| Other Liabilities + | 20 | 23 | 26 | 26 | 26 | 40 |
| Total Liabilities | 186 | 240 | 296 | 369 | 535 | 642 |
| Fixed Assets + | 24 | 36 | 36 | 50 | 54 | 253 |
| CWIP | 2 | 1 | 11 | 30 | 126 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 160 | 203 | 249 | 289 | 355 | 382 |
| Total Assets | 186 | 240 | 296 | 369 | 535 | 642 |
Financials of Gem Aromatics
Operating, investing and financing cash movement
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -0 | -5 | 15 | 40 | -25 | 30 |
| Cash from Investing Activity + | -5 | -15 | -18 | -50 | -92 | -101 |
| Cash from Financing Activity + | 7 | 18 | 6 | 15 | 103 | 78 |
| Net Cash Flow | 2 | -2 | 4 | 5 | -15 | 6 |
| Free Cash Flow | -6 | -19 | 1 | 1 | -130 | -65 |
| CFO/OP | 24% | 12% | 50% | 71% | 1% | 100% |
Financials of Gem Aromatics
Working capital efficiency and return ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 63 | 46 | 68 | 37 | 102 | 76 |
| Inventory Days | 120 | 206 | 164 | 187 | 161 | 309 |
| Days Payable | 23 | 27 | 24 | 20 | 23 | 25 |
| Cash Conversion Cycle | 160 | 225 | 208 | 203 | 241 | 360 |
| Working Capital Days | 90 | 110 | 102 | 121 | 116 | 179 |
| ROCE % | 25% | 25% | 24% | 19% | 3% |
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…